Tirzepatide, another GLP-1 agonist, often results in more weight loss
Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions
Participants reported fewer episodes of feeling unable to control their eating, suggesting that GLP-1RAs may help restore a sense of control over food intake
Renal outcomes SELECT kidney analysis : semaglutide reduced kidney composite outcomes by ~22%, consistent with renal-protective signals (Kristensen et al., 2024)
The abdominal wall has significantly higher subcutaneous blood flow
Semaglutide works through GLP-1 receptors alone, and Couture Med Spa describes it as "widely recognized for appetite regulation and sustained progress over time," though the practice notes individual results vary and some patients see changes sooner than others